Latest News

Insights on UCB’s Commitment to Advancing Rare Epilepsy Care
Insights on UCB’s Commitment to Advancing Rare Epilepsy Care

December 9th 2024

Fenfluramine Safe and Effective in Lennox-Gastaut Syndrome Regardless of Concomitant Vagus Nerve Stimulation
Fenfluramine Safe and Effective in Lennox-Gastaut Syndrome Regardless of Concomitant Vagus Nerve Stimulation

December 9th 2024

This Week on NeurologyLive® — December 9, 2024
This Week on NeurologyLive® — December 9, 2024

December 9th 2024

AES Poster Provides Safety Insights to Antiseizure Medication Fenfluramine
AES Poster Provides Safety Insights to Antiseizure Medication Fenfluramine

December 8th 2024

Coverage of the American Epilepsy Society Annual Meeting

Get direct access to interviews with experts, as well as the latest data and clinical news updates, straight from the conference floor in Los Angeles.

MDS 2024

Conference Coverage

View All
Insights on UCB’s Commitment to Advancing Rare Epilepsy Care
Insights on UCB’s Commitment to Advancing Rare Epilepsy Care

December 9th 2024

Fenfluramine Safe and Effective in Lennox-Gastaut Syndrome Regardless of Concomitant Vagus Nerve Stimulation
Fenfluramine Safe and Effective in Lennox-Gastaut Syndrome Regardless of Concomitant Vagus Nerve Stimulation

December 9th 2024

Therapeutic Optimization of Stiripentol for Dravet Syndrome: James Wheless, MD, FAAP, FAAN, FAES
Therapeutic Optimization of Stiripentol for Dravet Syndrome: James Wheless, MD, FAAP, FAAN, FAES

December 9th 2024

Video Series
Video Interviews
Podcasts

Most Recent

© 2024 MJH Life Sciences

All rights reserved.